I agree with some of the sentiment expressed in this post. Moats- correct, however this Company has several significant tail winds in my opinion. 1- rapidly expanding legal cannabis market 2- the Company is run by the major shareholder 3-they appear nimble and have identified the principal growth area within a high growth market 4-they do have a brand- Dr Watson - which will get built out over time 5- they have international access to supply rather than being fixed to their own locally farmed supply.
Sure, one of the opportunities here in Australia is B to B, however I would rather be with a nimble committed Company where the leader also holds the largest shareholding rather than investing my hard earned with the cannabis farmers. With the growth opportunities available here in Australia and worldwide, this story has 5 years in front of it before we need to discuss whether tears are shed.
For BXN, the challenge is to execute. We will know soon.
BXN Price at posting:
1.3¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)